<?xml version="1.0" encoding="UTF-8"?>
<ref id="B269-pharmaceuticals-12-00147">
 <label>269.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kogure</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Miyamoto</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hidari</surname>
    <given-names>K.I.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>C.T.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kawaoka</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Human trachea primary epithelial cells express both sialyl(alpha2-3)Gal receptor for human parainfluenza virus type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal receptor for human influenza viruses</article-title>
  <source>Glycoconj. J.</source>
  <year>2006</year>
  <volume>23</volume>
  <fpage>101</fpage>
  <lpage>106</lpage>
  <pub-id pub-id-type="doi">10.1007/s10719-006-5442-z</pub-id>
  <?supplied-pmid 16575527?>
  <pub-id pub-id-type="pmid">16575527</pub-id>
 </element-citation>
</ref>
